首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2018年 2期丙型肝炎的治疗 => 肝脏肿瘤 =>加速康复外科与传统康复方案在肝切..
加速康复外科与传统康复方案在肝切除术中应用比较的Meta分析
Application of enhanced recovery after surgery versus traditional rehabilitation program in hepatectomy: a Meta-analysis
文章发布日期:2018年01月05日  来源:  作者:李乐,陈金明,刘中华,等  点击次数:733次  下载次数:106次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的评价加速康复外科(ERAS)与传统康复方案在肝切除术中的应用效果。方法文献检索到2016年8月,在PubMed、EBSCO、MEDLINE及Cochrane数据库中检索ERAS与传统康复方案在肝脏外科中应用效果比较的文献,2名单独观察者根据纳入与排除标准进行质量评价与数据提取后,采用RevMan5.3.5软件进行Meta分析。结果共纳入4篇文献,共524例患者,其中254例为ERAS组,270例为传统治疗组。ERAS组术后住院时间明显优于传统治疗组[加权均数差(WMD)=-2.72,95%可信区间(95%CI):-3.86~-1.57,P<0.000 01];ERAS组功能恢复时间明显早于传统治疗组(WMD=-2.67,95%CI:-3.68~-1.65,P< 0.000 01);ERAS组总并发症发生率明显少于传统治疗组[比值比(OR)=0.45,95%CI:0.30~0.67,P<0.000 1],亚组分析1级并发症及2~5级并发症的发生率ERAS组也具有明显优势(OR=0.55,95%CI:0.31~0.98,P<0.05;OR=0.49,95%CI:0.32~0.76,P<0.05);2组再住院率比较无统计学意义(P>0.05);术后1 d及3 d C反应蛋白含量2组比较差异无统计学意义(P值均>0.05),而术后5 d ERAS组C反应蛋白含量明显小于传统治疗组(WMD=-21.68,95%CI:-29.30~-1405,P<0.000 1);ERAS组术后第1次排气时间明显早于传统治疗组(WMD=-0.93,95%CI:-1.41~-0.46,P=0.000 1)。结论ERAS在肝脏外科中的应用是安全、有效且可行的。
【Abstract】:ObjectiveTo investigate the effect of enhanced recovery after surgery (ERAS) versus traditional rehabilitation program in patients undergoing hepatectomy. MethodsPubMed, EBSCO, MEDLINE, and Cochrane Library were searched for the articles on the effect of ERAS versus traditional rehabilitation program in liver surgery published up to August 2016. Two independent observers performed quality assessment and data extraction according to the inclusion and exclusion criteria, and RevMan 5.3.5 was used for the Meta-analysis. ResultsA total of 4 articles with 524 patients (254 patients in ERAS group and 270 in traditional treatment group) were included. Compared with the traditional treatment group, the ERAS group had significantly shorter length of postoperative hospital stay (weighted mean difference [WMD]=-2.72, 95% confidence interval [CI]: -3.86 to -1.57, P<0.000 01), shorter time to functional recovery (WMD=-2.67, 95% CI: -3.68 to -1.65, P<0.000 01), and lower overall incidence rate of complications (odds ratio [OR]=0.45, 95% CI: 0.30-0.67, P<0.000 1). The subgroup analysis showed that the ERAS group also had significantly lower incidence rates of grade 1 and grade 2-5 complications than the traditional treatment group (grade 1: OR=0.55, 95% CI: 0.31-0.98, P<0.05; grade 2-5: OR=0.49, 95% CI: 0.32-0.76, P<0.05). There was no significant difference in rehospitalization rate between the two groups (P>0.05). As for the level of C-reactive protein, there was no significant difference between the two groups at 1 and 3 days after surgery (P>0.05), but the ERAS group had a significantly lower level than the traditional treatment group at 5 days after surgery (WMD=-21.68, 95% CI: -29.30 to -14.05, P<0.000 1). The ERAS group also had a significantly shorter time to first flatus than the traditional treatment group (WMD=-0.93, 95% CI: -1.41 to -0.46, P=0.000 1). ConclusionERAS is safe, effective, and feasible in liver surgery.
【关键字】:肝肿瘤; 肝切除术; 加速康复外科; Meta分析
【Key words】:liver neoplasms; hepatectomy; enhanced recovery after surgery; Meta-analysis
【引证本文】:LI L, CHEN JM, LIU ZH, et al. Application of enhanced recovery after surgery versus traditional rehabilitation program in hepatectomy: a meta-analysis[J]. J Clin Hepatol, 2018, 34(2): 303-308. (in Chinese)
李乐, 陈金明, 刘中华, 等. 加速康复外科与传统康复方案在肝切除术中应用比较的Meta分析[J]. 临床肝胆病杂志, 2018, 34(2): 303-308.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号